A lot could happen on the trade front in the next few weeks, from pressuring Russia on Ukraine to arguing the legality of the ...

President Donald Trump is readying plans for industry-specific tariffs to kick in alongside his country-by-country duties in ...

President Trump has threatened to levy tariffs of up to 200% on pharmaceutical imports. Lilly's margins could be negatively ...

The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...

President Trump is reportedly pushing for higher blanket tariffs on imports from the European Union, throwing a wrench in ...

Despite former President Donald Trump’s threat of a 200% tariff on imported drugs during a cabinet meeting, pharmaceutical investors have shown surprisingly positive sentiment this week. Despite ...

In addition to measures on copper, the U.S. has discussed making announcements on lumber, chips, critical minerals and drugs ...

The Treasurer says he is evaluating the impact of US drug tariffs on the Pharmaceutical Benefits Scheme but says subsidies ...

Amgen Inc. (NASDAQ:AMGN) is one of the high-margin pharma stocks to buy now. HSBC has lowered its price target on Amgen Inc.

CIO & PM of leading sector ETF explains what has been impacting leading names and why he still sees strong long-term ...

Exporters from engineering, plastics and pharmaceuticals said delayed tariff decisions from Washington had stalled expansion plans, pushed back new US orders and clouded short-term growth.

Getinge's quarterly earnings beat market expectations on Friday, driven by organic sales growth across its business areas and regions, as the medical equipment maker seeks ways beyond pricing to ...